Consistent with these findings, our data indicate that compared to the control participants, both T2DM and cardiodiabetic patients exhibited higher levels of BMI, fasting blood glucose, and HbA1c, and lower levels of ApoA1. Here, APOA1 is linked to type 2 diabetes mellitus.